Becklund Irene, serving as Principal Accounting Officer (PAO) at Hims & Hers Health (HIMS), has demonstrated a consistent pattern of selling activity in the company’s stock, with no recorded purchases across 28 reported transactions. Since September 2025, Becklund has executed three notable sales totaling $870,683.46, including a $424,705 disposition on September 17, 2025, followed by a $308,767.81 sale on December 17, 2025, and a $136,511.01 transaction on March 17, 2026. These sales were accompanied by multiple smaller transactions coded as "M" (likely option exercises or other non-sale dispositions) with no reported value. The filings also include a $144,458.64 transaction on March 13, 2026, and a $321,428.75 transaction on December 15, 2025, both coded as "F" (likely representing tax withholdings or other mandatory transactions).
Becklund’s trading history reveals an exclusive focus on HIMS, with all activity concentrated in this single company. The absence of any buy transactions and the repeated sales—particularly the three largest in late 2025 and early 2026—suggest a sustained reduction in holdings. The dollar values indicate material dispositions, with individual sales ranging from the mid-six figures to over $400,000. While the filings do not specify whether these sales were pre-planned (e.g., under Rule 10b5-1 plans), the pattern aligns with a gradual unwinding of equity exposure rather than an abrupt exit. The consistency of these transactions, spaced roughly quarterly, may reflect a structured approach to liquidity events.
AI-assisted summary